The study presents cross-country comparisons of the health status of populations and the performance of health systems in OECD countries.
The key findings of the publication are as follows.
-New drugs will push pharmaceutical spending unless policy adapts
-Life expectancy continues to rise, but widespread differences persist across countries and socio-demographic groups
-The number of doctors and nurses have never been higher in OECD countries
-Out-of-pocket spending remains a barrier to accessing care
-Too many lives are still lost because quality of care is not improving fast enough
This edition offers two new futures: a set of dashboard indicators on health outcomes and health systems and a special chapter on recent trends in pharmaceutical spending across OECD countries.
The whole report is available for the IESE Community here.